查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1701257

組織學和細胞學市場規模、佔有率、趨勢分析報告（按測試類型、產品、應用、地區、細分市場預測），2025 年至 2030 年

Histology And Cytology Market Size, Share & Trends Analysis Report By Type of Examination (Histology, Cytology), By Product (Instruments & Analysis Software System, Consumables & Reagents), By Application, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

組織學和細胞學市場的成長和趨勢：

根據 Grand View Research 的新報告，到 2030 年全球組織學和細胞學市場預計將達到 494.8 億美元。

預計從 2025 年到 2030 年，市場複合年成長率為 15.31%。推動市場成長的因素包括對疾病早期檢測的需求不斷增加、病理實驗室標準化程度不斷提高、免疫組織化學的引入以及顯微鏡技術的創新。

每個組織都致力於合作實現細胞病理學的全球標準化，從而對市場成長產生積極影響。例如，2022 年 11 月在肯亞建立了新的 IARC GICR 合作中心，旨在透過培訓推動撒哈拉以南非洲的癌症登記工作。該聯合中心將專注於區域培訓課程以及CanReg5軟體的實施和開發。

此外，各公司正在推出新型自動化細胞學儀器，這進一步促進了組織學和細胞學產業的發展。例如，2021 年 1 月，F. Hoffmann-La Roche Ltd 推出了兩種自動化數位病理演算法：uPath HER2 (4B5) 影像和 uPath HER2 Dual ISH 成像。

COVID-19 已成為透過整合人工智慧 (AI)數位化解決方案來改變傳統病理學工作流程的催化劑。在疫情期間，這些工具支援並將繼續支援病理病例的遠端審查。這有助於防止患者護理的延遲。公司報告稱，自 COVID-19 爆發以來，數位病理學解決方案的採用率有所提高。

組織學和細胞學市場報告重點

  • 預計細胞學領域將在 2024 年佔據最大的收益佔有率，並且由於計算分析工具與細胞學系統進步的結合，預計在預測期內將繼續保持這一趨勢。
  • 由於耗材市場中企業發展的公司組合不斷擴大，耗材和試劑部分在組織學和細胞學產業中佔據主導地位。由於對自動化組織檢測儀器的需求激增，預計儀器和分析軟體系統領域將在 2025 年至 2030 年間以顯著的複合年成長率成長。
  • 預計藥物發現和設計領域將在 2024 年佔據最高的收益佔有率，並且預計在預測期內將以最快的複合年成長率成長。
  • 由於癌症的流行、主要參與者的存在以及發達的醫療保健基礎設施，北美已成為 2024 年收益最高的地區。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 組織學和細胞學市場變數、趨勢和範圍

  • 市場展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 組織學和細胞學市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 定價分析

4. 組織學和細胞學市場：測試類型估計和趨勢分析

  • 全球組織學與細胞學市場：儀表板
  • 全球組織學與細胞學市場：變異分析
  • 全球組織學與細胞學市場：收益
  • 組織學
    • 依技術
  • 細胞學
    • 依技術
    • 按應用

5. 組織學與細胞學市場：產品估計與趨勢分析

  • 全球組織學與細胞學市場：產品儀表板
  • 全球組織學與細胞學市場：產品差異分析
  • 全球組織學和細胞學市場收益（按產品）
    • 儀器和分析軟體系統
    • 耗材和試劑

6. 組織學和細胞學市場：應用估計和趨勢分析

  • 全球組織學與細胞學市場：應用儀表板
  • 全球組織學與細胞學市場：應用差異分析
  • 全球組織學和細胞學市場收益（按應用）
  • 藥物發現與設計
  • 臨床診斷
    • 照護現場（PoC）
    • 非 PoC
  • 研究

第7章組織學和細胞學市場：按測試類型、產品、應用和調查方法進行的區域估計和趨勢分析

  • 區域儀表板
  • 市場規模、預測趨勢分析，2018 年至 2030 年：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭格局

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 主要經銷商和通路合作夥伴名單
    • Key customers
    • Key company market share analysis, 2024
    • Hologic, Inc.
    • Abbott
    • Becton, Dickinson and Company
    • F. Hoffmann-La Roche Ltd
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Danaher
    • Sysmex Corporation
    • Trivitron Healthcare
    • Koninklijke Philips NV
Product Code: GVR-1-68038-917-3

Histology And Cytology Market Growth & Trends:

The global histology and cytology market size is anticipated to reach USD 49.48 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 15.31% from 2025 to 2030. The factors contributing to market growth include increasing demand for early detection of diseases, increased standardization of pathology laboratories, and implementation of immunohistochemistry and innovation in microscopy.

Organizations are focusing on collaborations for the standardization of cytopathology globally, positively impacting market growth. For instance, in November 2022, a novel IARC GICR collaboration center was established in Kenya to advance cancer registration in sub-Saharan Africa via training. The collaborating center focuses on regional training courses and the implementation & development of the CanReg5 software.

Moreover, companies are launching novel and automated instruments for cytology which can be further attributed to the histology and cytology industry growth. For instance, in January 2021, F. Hoffmann-La Roche Ltd launched uPath HER2 (4B5) image analysis and uPath HER2 Dual ISH image analysis-two automated digital pathology algorithms that offer rapid & accurate patient diagnoses in breast cancer.

COVID-19 became a catalyst for changing traditional pathology workflows with the integration of artificial intelligence (AI) and digitalization solutions. During the pandemic, these tools helped and continue to assist in the remote reviewing of pathological cases. Thus, preventing delays in patient care. Companies have reported increasing adoption of digital pathology solutions post-COVID-19.

Histology And Cytology Market Report Highlights:

  • The cytology segment accounted for the largest revenue share in 2024 and is expected to continue the trend in the forecast period owing to the integration of computational analytical tools for advancing cytology systems
  • The consumables and reagents segment dominated the histology and cytology industry, attributed to the expanding portfolios of the entities operating in the consumable market. The instruments and analysis software system segment is expected to grow at a substantial CAGR from 2025 to 2030, attributed to the steep increase in the demand for automated histology instruments
  • Drug discovery & designing segment accounted for the highest revenue share in 2024 and is anticipated to grow at the fastest CAGR over the forecast period, owing to the growing importance of cytopathology in disease understanding, further aimed at rapid drug development
  • North America emerged as the highest revenue-generating region in 2024, owing to the prevalence of cancer, the presence of key players, and the developed healthcare infrastructure

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type of Examination
    • 1.2.2. Product
    • 1.2.3. Application
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type of examination outlook
    • 2.2.2. Product outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Histology and Cytology Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising incidence of cancer
      • 3.2.1.2. Technological developments
      • 3.2.1.3. Increase in awareness programs for cervical cancer screening
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Low sensitivity of cytology tests
      • 3.2.2.2. Conditions required for specimens and problem of mislabeled specimens
  • 3.3. Histology and cytology Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pricing Analysis

Chapter 4. Histology and cytology Market: Type of Examination Estimates & Trend Analysis

  • 4.1. Global Histology and Cytology Market: Type Of Examination Dashboard
  • 4.2. Global Histology and Cytology Market: Type of Examination Movement Analysis
  • 4.3. Global Histology and Cytology Market by Type of Examination, Revenue
  • 4.4. Histology
    • 4.4.1. Histology market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. By Technique
      • 4.4.2.1. Microscopy
        • 4.4.2.1.1. Microscopy market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.2. Immunohistochemistry
        • 4.4.2.2.1. Immunohistochemistry market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.3. Molecular pathology
        • 4.4.2.3.1. Molecular pathology market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.4. Cryostat & Microtomy
        • 4.4.2.4.1. Cryostat & Microtomy market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Cytology
      • 4.4.3.1. Cytology market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. By Technique
      • 4.4.4.1. Microscopy
        • 4.4.4.1.1. Microscopy market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.4.2. Immunohistochemistry
        • 4.4.4.2.1. Immunohistochemistry market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.4.3. Molecular pathology
        • 4.4.4.3.1. Molecular pathology market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.4.4. Cryostat & Microtomy
        • 4.4.4.4.1. Cryostat & Microtomy market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. By Application
      • 4.4.5.1. Breast Cancer
        • 4.4.5.1.1. Breast Cancer market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.5.2. Cervical Cancer
        • 4.4.5.2.1. Cervical Cancer market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.5.3. Bladder Cancer
        • 4.4.5.3.1. Bladder Cancer market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.5.4. Lung Cancer
        • 4.4.5.4.1. Lung Cancer market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.5.5. Other Cancers
        • 4.4.5.5.1. Other Cancer market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Histology and cytology Market: Product Estimates & Trend Analysis

  • 5.1. Global Histology and Cytology Market: Product Dashboard
  • 5.2. Global Histology and Cytology Market: Product Movement Analysis
  • 5.3. Global Histology and Cytology Market by Product, Revenue
    • 5.3.1. Instruments and Analysis Software System
    • 5.3.2. Instruments and analysis software system market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Consumable and Reagents
    • 5.3.4. Consumable and reagents market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Histology and cytology Market: Application Estimates & Trend Analysis

  • 6.1. Global Histology and Cytology Market: Application Dashboard
  • 6.2. Global Histology and Cytology Market: Application Movement Analysis
  • 6.3. Global Histology and Cytology Market by Application, Revenue
  • 6.4. Drug Discovery & Designing
    • 6.4.1. Drug discovery & designing market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Clinical Diagnostics
    • 6.5.1. Clinical diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Point-of-Care (PoC)
      • 6.5.2.1. Point-of-Care (PoC) market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Non-PoC
      • 6.5.3.1. Non-PoC market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Research
    • 6.6.1. Research market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Histology and cytology Market: Regional Estimates & Trend Analysis by Type of Examination, Product, Application and Methodology

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. Hologic, Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Abbott
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Becton, Dickinson and Company
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. F. Hoffmann-La Roche Ltd
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Merck KGaA
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Thermo Fisher Scientific, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Danaher
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Sysmex Corporation
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Trivitron Healthcare
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Koninklijke Philips N.V.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Histology and cytology market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 4 North America Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 7 U.S. Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 9 Canada Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 10 Canada Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 12 Mexico Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 13 Mexico Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 14 Mexico Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 15 Europe Histology and cytology market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 17 Europe Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 19 Germany Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 20 Germany Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 21 Germany Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 22 UK Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 23 UK Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 24 UK Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 25 France Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 26 France Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 27 France Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 28 Italy Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 29 Italy Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 30 Italy Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 31 Spain Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 32 Spain Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 33 Spain Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 34 Denmark Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 35 Denmark Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 36 Denmark Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 37 Sweden Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 38 Sweden Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 39 Sweden Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 40 Norway Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 41 Norway Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 42 Norway Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Histology and cytology market, by region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 47 China Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 48 China Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 49 China Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 50 Japan Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 51 Japan Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 52 Japan Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 53 India Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 54 India Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 55 India Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 56 South Korea Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 57 South Korea Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 59 Australia Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 60 Australia Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 62 Thailand Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 63 Thailand Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 64 Thailand Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 65 Latin America Histology and cytology market, by region, 2018 - 2030 (USD Million)
  • Table 66 Latin America Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 67 Latin America Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 68 Latin America Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 69 Brazil Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 70 Brazil Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 71 Brazil Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 72 Argentina Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 73 Argentina Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 75 MEA Histology and cytology market, by region, 2018 - 2030 (USD Million)
  • Table 76 MEA Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 77 MEA Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 78 MEA Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 79 South Africa Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 80 South Africa Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 85 UAE Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 86 UAE Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE Histology and cytology market, by product, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Histology and cytology market, by type of examination, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Histology and cytology market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Histology and cytology market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Histology and cytology market: market outlook
  • Fig. 14 Histology and cytology competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Histology and cytology market driver impact
  • Fig. 18 Histology and cytology market restraint impact
  • Fig. 19 Histology and cytology market: Type of examination movement analysis
  • Fig. 20 Histology and cytology market: Type of examination outlook and key takeaways
  • Fig. 21 Histology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Microscopy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Immunohistochemistry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Molecular pathology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Cryostat & microtomy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Cytology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Microscopy estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Immunohistochemistry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Molecular pathology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Cryostat & microtomy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Cervical Cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Breast Cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Bladder Cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Lung Cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Other Cancers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Histology and cytology market: Product movement analysis
  • Fig. 37 Histology and cytology market: Product outlook and key takeaways
  • Fig. 38 Instruments and analysis software system market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Consumable and reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Histology and cytology market: Application movement analysis
  • Fig. 41 Histology and cytology market: Application outlook and key takeaways
  • Fig. 42 Drug discovery & designing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Clinical diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Point-of-Care (PoC) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Non-PoC market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Research market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Global Histology and Cytology market: Regional movement analysis
  • Fig. 48 Global Histology and Cytology market: Regional outlook and key takeaways
  • Fig. 49 Global Histology and Cytology market share and leading players
  • Fig. 50 North America, by country
  • Fig. 51 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 U.S. key country dynamics
  • Fig. 53 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Canada key country dynamics
  • Fig. 55 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Mexico key country dynamics
  • Fig. 57 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 UK key country dynamics
  • Fig. 60 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Germany key country dynamics
  • Fig. 62 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 France key country dynamics
  • Fig. 64 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Italy key country dynamics
  • Fig. 66 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Spain key country dynamics
  • Fig. 68 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Denmark key country dynamics
  • Fig. 70 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Sweden key country dynamics
  • Fig. 72 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Norway key country dynamics
  • Fig. 74 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 China key country dynamics
  • Fig. 77 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Japan key country dynamics
  • Fig. 79 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 India key country dynamics
  • Fig. 81 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Thailand key country dynamics
  • Fig. 83 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 South Korea key country dynamics
  • Fig. 85 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Australia key country dynamics
  • Fig. 87 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Brazil key country dynamics
  • Fig. 90 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Argentina key country dynamics
  • Fig. 92 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 South Africa key country dynamics
  • Fig. 95 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Saudi Arabia key country dynamics
  • Fig. 97 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 UAE key country dynamics
  • Fig. 99 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Kuwait key country dynamics
  • Fig. 101 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Market share of key market players- Histology and cytology market